,

Yang Chen1,2, Qingrong Liu1,3, Hongliang Zhang1

  • 1Department of Cardiology, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.

概括

新型ScienCrown跨导管大动脉置换系统 (TAVR) 在严重的大动脉狭窄症 (AS) 患者中显示出出色的安全性和有效性. 一年后的结果显示,死亡率,血液动力学和生活质量有显著改善.